Katrin Kohl

Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events

Alena Khromava, Rachel B. Eidex, Leisa Weld et al. · Vaccine · 2005 · 216 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

A whole-institution approach towards sustainability: a crucial aspect of higher education’s individual and collective engagement with the SDGs and beyond

Katrin Kohl, Charles Hopkins, Matthias Barth et al. · International Journal of Sustainability in Higher Education · 2021 · 213 citations · Full text

Education, Education Policy, Higher Education +16

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

James J. Sejvar, Katrin Kohl, Roman Bilynsky et al. · Vaccine · 2007 · 192 citations

Medicine, Immunology, Infectious Diseases +14

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)

Jan Bonhoeffer, Katrin Kohl, Robert HC Chen et al. · Vaccine · 2002 · 160 citations

Medicine, Health Policy, Infectious Diseases +16

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17